Jette Lautrup Fredriksen

Jette Lautrup Fredriksen

Clinical Professor

Member of:

  • Neurology

ORCID: 0000-0003-1661-7438

Publication year:
All
1 - 10 out of 88Page size: 10
  1. 2003
  2. Published

    Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

    Sorensen, P. S., Pedersen, Christian Ross, Clemmesen, K. M., Bendtzen, K., Fredriksen, Jette Lautrup, Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E., Koch-Henriksen, N. & Danish Multiple Sclerosis Study Group, D. M. S. S. G., 11 Oct 2003, In: Lancet. 362, 9391, p. 1184-91 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Antibodies to IFN-beta: the Danish National IFN-beta Project

    Sorensen, P. S., Pedersen, Christian Ross, Clemmesen, K. M., Bendtzen, K., Fredriksen, Jette Lautrup, Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E., Koch-Henriksen, N. & Danish Multiple Sclerosis Study Group, D. M. S. S. G., 11 Nov 2003, In: Neurology. 61, 9 Suppl 5, p. S27-8

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. 2004
  5. Published

    Betydningen af neutraliserende antistoffer mod interferon-beta hos patienter med attakvis multipel sklerose

    Sørensen, Per Soelberg, Koch-Henriksen, N., Pedersen, C. R., Clemmesen, K. M., Bendtzen, K., Fredriksen, Jette Lautrup, Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E. & Dansk Multipel Sklerose Gruppe, D. M. S. G., 4 Oct 2004, In: Ugeskrift for Laeger. 166, 41, p. 3606-9 4 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. 2005
  7. Published

    CD26 + CD4 + T cell counts and attack risk in interferon-treated multiple sclerosis

    Sellebjerg, Finn Thorup, Pedersen, Christian Ross, Koch-Henriksen, N., Sørensen, Per Soelberg, Fredriksen, Jette Lautrup, Bendtzen, K. & Sørensen, Torben Lykke, 1 Dec 2005, In: Multiple Sclerosis. 11, 6, p. 641-5 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. 2008
  9. Published

    Normal levels of cerebrospinal fluid hypocretin-1 and daytime sleepiness during attacks of relapsing-remitting multiple sclerosis and monosymptomatic optic neuritis

    Knudsen, S., Jennum, Poul, Korsholm, K., Sheikh, S. P., Gammeltoft, S. & Fredriksen, Jette Lautrup, 1 Jul 2008, In: Multiple Sclerosis. 14, 6, p. 734-8 5 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. 2009
  11. Published

    Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial

    Comi, G., Martinelli, V., Rodegher, M., Moiola, L., Bajenaru, O., Carra, A., Elovaara, I., Fazekas, F., Hartung, H. P., Hillert, J., King, J., Komoly, S., Lubetzki, C., Montalban, X., Myhr, K. M., Ravnborg, M., Rieckmann, P., Wynn, D., Young, C., Filippi, M. & 2 others, Fredriksen, Jette Lautrup & PreCISe study group, P. S. G., 2009, In: Lancet. 374, 9700, p. 1503-1511 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  12. Published

    Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study

    O'Connor, P., Comi, G., Montalban, X., Antel, J., Radue, E. W., de Vera, A., Pohlmann, H., Kappos, L., Fredriksen, Jette Lautrup & FTY720 D2201 Study Group, F. D. S. G., 6 Jan 2009, In: Neurology. 72, 1, p. 73-9 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Management of optic neuritis and impact of clinical trials: an international survey

    Biousse, V., Calvetti, O., Drews-Botsch, C. D., Atkins, E. J., Sathornsumetee, B., Newman, N. J., Optic Neuritis Survey Group, Fredriksen, Jette Lautrup & Optic Neuritis Survey Group, O. N. S. G., 15 Jan 2009, In: Journal of the Neurological Sciences. 276, 1-2, p. 69-74 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. Published

    Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial

    Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H., Miller, D. H., Montalbán, X., Barkhof, F., Radü, E., Metzig, C., Bauer, L., Lanius, V., Sandbrink, R., Pohl, C., Fredriksen, Jette Lautrup & BENEFIT Study Group, B. S. G., 1 Nov 2009, In: Lancet Neurology Network. 8, 11, p. 987-97 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  15. Published

    MRI as an outcome in multiple sclerosis clinical trials

    Sormani, M. P., Filippi, M., De Stefano, N., Ebers, G., Daumer, M., Fredriksen, Jette Lautrup & MAGNIMS Steering Committee, M. S. C., 1 Dec 2009, In: Neurology. 73, 22, p. 1932; author reply 1932-3

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 9 Next

ID: 982687